Evidence map›Paper›PMID 41150388›Full record

ArticleVaccines2025

Respiratory Efficacy of a Multivalent Marker Vaccine Against Bovine Viral Diarrhoea Virus Types 1 and 2, Infectious Bovine Rhinotracheitis Virus, Bovine Respiratory Syncytial Virus, and Bovine Parainfluenza-3 Virus in Young Calves.

Carlos Montbrau, Marta Gibert, Marina Solé, Isabel Barril, Mercè Roca, Lucia Acal, Berta Vázquez, Joaquim Mallorqui, Ricard March

Abstract read
In one paragraph

Article in Vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Carlos MontbrauHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.ORCID 0000-0003-0563-6414
Marta GibertHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.
Marina SoléHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.
Isabel BarrilHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.
Mercè RocaHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.
Lucia AcalHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.
Berta VázquezHIPRA S.A., Avinguda La Selva 135, 17170 Amer, Spain.
Joaquim MallorquiHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.
Ricard MarchHipra Scientific, S.L.U., Avinguda La Selva 135, 17170 Amer, Spain.ORCID 0000-0003-2396-4163

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

bovine herpesvirus type 1 (BoHV-1)bovine parainfluenza-3 virus (PI-3)bovine respiratory disease (BRD)bovine respiratory syncytial virus (BRSV)bovine viral diarrhoea virus (BVDV)experimental infectioninfectious bovine rhinotracheitis virus (IBR)vaccine

Identifiers

PMID41150388
PMCPMC12568246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.